When TAMs infiltrate in TME, they secrete HGF that leads to stimulation of PI3K/Akt, MAPK and c-Met pathways in increasing progression of HCC cells, resulting in sorafenib resistance [127]. Here, AKT1 is linked to hepatocellular carcinoma.